DAWN · Day One Biopharmaceuticals, Inc.
$21.53
+0.00 (+0.00%)
At close · Apr 24
Market Cap
$2.22B
Shares
103.33M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-04-23 | 2026-04-22 | |
| 10-K/A | 2026-04-17 | 2025-12-31 | |
| 8-K/A | 2026-03-09 | 2026-01-06 | |
| 8-K | 2026-03-06 | — | |
| 8-K | 2026-03-02 | — | |
| 10-K | 2026-02-24 | 2025-12-31 | |
| 8-K | 2026-02-24 | — | |
| 8-K | 2026-01-12 | 2026-01-11 | |
| 8-K | 2026-01-06 | — | |
| 8-K | 2025-11-24 | — | |
| 8-K | 2025-11-13 | 2025-11-12 | |
| 10-Q | 2025-11-04 | 2025-09-30 | |
| 8-K | 2025-11-04 | — | |
| 8-K | 2025-10-10 | 2025-10-07 | |
| 10-Q | 2025-08-05 | 2025-06-30 | |
| 8-K | 2025-08-05 | — | |
| 8-K | 2025-06-03 | 2025-06-02 | |
| 10-Q | 2025-05-06 | 2025-03-31 | |
| 8-K | 2025-05-06 | — | |
| DEF 14A | 2025-04-11 | 2025-06-02 | |
| 10-K/A | 2025-03-06 | 2024-12-31 | |
| 8-K | 2025-02-25 | — | |
| 10-K | 2025-02-25 | 2024-12-31 | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-11-20 | — | |
| 10-Q | 2024-10-30 | 2024-09-30 | |
| 8-K | 2024-10-30 | — | |
| 10-Q | 2024-08-02 | 2024-06-30 | |
| 8-K | 2024-07-30 | — | |
| 8-K | 2024-07-30 | — | |
| 8-K | 2024-07-25 | 2024-07-23 | |
| 8-K | 2024-06-18 | 2024-06-17 | |
| 8-K | 2024-06-12 | — | |
| 8-K | 2024-05-30 | 2024-05-29 | |
| 8-K | 2024-05-24 | 2024-05-23 | |
| 8-K | 2024-05-06 | — | |
| 10-Q | 2024-05-06 | 2024-03-31 | |
| 8-K | 2024-04-24 | 2024-04-23 | |
| DEF 14A | 2024-04-05 | 2024-05-23 | |
| 8-K | 2024-03-07 | 2024-03-04 | |
| 8-K | 2024-02-26 | — | |
| 10-K | 2024-02-26 | 2023-12-31 | |
| 8-K | 2024-01-17 | 2024-01-16 | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-12-08 | 2023-12-07 | |
| 8-K | 2023-11-17 | — | |
| 8-K | 2023-11-15 | 2023-11-10 | |
| 10-Q | 2023-11-06 | 2023-09-30 | |
| 8-K | 2023-11-06 | — | |
| 8-K | 2023-10-30 | — |
Showing 1–50 of 89 filings